* Labcorp , Laboratory Corporation of America, any associated logos, and all associated Labcorp registered or unregistered trademarks are the property of Laboratory Corporation of America.
Cotinine which is the primary metabolite of nicotine and can be detected for as long as seven days after exposure.
The testing cutoff is set at a high level to rule out passive inhalation.
Chain of Custody Forensic Test for Cotinine a metabolite of Nicotine
The Labcorp Cotinine Test is a specific test designed to detect the presence of cotinine, a metabolite of nicotine, in a person’s system. Cotinine is produced when the body metabolizes nicotine after tobacco or nicotine product use. This test is often used to determine whether an individual has been exposed to nicotine or is actively using tobacco or nicotine products.
The Labcorp Cotinine Test is typically performed on a urine or blood sample. It can provide information about a person’s nicotine or tobacco use within a certain time frame, usually the past few days to weeks, depending on the type of sample collected.
The results of the Labcorp Cotinine Test are reported as either positive or negative, indicating the presence or absence of cotinine in the sample. A positive result indicates recent nicotine exposure, while a negative result suggests the absence of recent nicotine or tobacco use.
The Labcorp Cotinine Test is commonly used in various settings, including:
- Employment and Workplace Testing: Some employers or organizations may require cotinine testing as part of their pre-employment screening or ongoing employee monitoring to assess tobacco or nicotine use.
- Insurance and Health Assessments: Health and life insurance companies may request cotinine testing as part of their underwriting process to determine tobacco use, as it can impact premiums or coverage eligibility.
- Research and Clinical Studies: Cotinine testing is utilized in research studies and clinical trials to monitor and assess tobacco or nicotine exposure in participants.